D. Magnetta

Cost-Effectiveness of Ventricular Assist Device Destination Therapy for Advanced Heart Failure in Duchenne Muscular Dystrophy

Kenneth J. Smith, P. Wearden, D. Magnetta, 2018, Pediatric Cardiology.

Impact of the 2016 revision of US Pediatric Heart Allocation Policy on waitlist characteristics and outcomes

D. Magnetta, B. Feingold, J. Godown, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Biventricular Assist Device Support for Intractable Arrhythmias From Histiocytoid Cardiomyopathy.

A. Joong, D. Magnetta, G. Webster, 2022, ASAIO journal.

Clinical approach to antibody‐mediated rejection from the pediatric heart transplant society

J. Conway, H. Henderson, J. Alejos, 2022, Pediatric transplantation.

Clinical approach to acute cellular rejection from the pediatric heart transplant society

N. Bansal, J. Conway, S. Deshpande, 2022, Pediatric transplantation.

Donor-specific antibodies after heart transplantation for Fontan-associated protein-losing enteropathy.

D. Magnetta, E. Pahl, P. Thrush, 2023, Pediatric transplantation.

Worsening racial disparity in waitlist mortality for pediatric heart transplant candidates since the 2016 Pediatric Heart Allocation Policy revision

T. M. Hoffman, D. Magnetta, Christina M. Phelps, 2021, Pediatric transplantation.

Mitochondrial cardiomyopathy and ventricular arrhythmias associated with biallelic variants in C1QBP

Nicoleta C. Arva, A. George, N. Arva, 2021, American journal of medical genetics. Part A.

Prognostic Value of RV Function Analysis During the Interstage Period in Patients with Hypoplastic Left Heart Syndrome.

D. Magnetta, Jamie S. Penk, N. Husain, 2024, Pediatric cardiology.